MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Income Statement

Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma, Inc. (TBPH)

source: myfinsight.com
Net income (loss)-$5,898K (-110.76%↓ Y/Y)Income (loss) beforeincome taxes-$4,791K (-106.54%↓ Y/Y)Provision for income tax(expense) benefit$1,107K (-93.97%↓ Y/Y)Interest and otherincome, net$3,486K (139.26%↑ Y/Y)Gain from operations-$8,277K (-203.74%↓ Y/Y)Total revenues$20,731K (-20.86%↓ Y/Y)Total expenses$29,008K (0.30%↑ Y/Y)Selling, general andadministrative$14,176K (-23.08%↓ Y/Y)Transaction-related expenses$6,089K Research and development$4,712K (-55.08%↓ Y/Y)Restructuring expenses$4,031K